You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
SKUP3 trial: comment
  1. John Stradling1,
  2. Malcolm Kohler2
  1. 1 Oxford Centre for Respiratory Medicine, Oxford University, Churchill Hospital Campus, Oxford, UK
  2. 2 Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland
  1. Correspondence to Professor J Stradling, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford OX3 7LJ, UK; john.stradling{at}orh.nhs.uk

https://doi.org/10.1136/thoraxjnl-2013-204476

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The paper on uvulopalatopharyngoplasty (the SKUP3 trial, September 2013 issue of Thorax) is a significant contribution to the literature on the surgical management of obstructive sleep apnea (OSA).1 The authors are to be congratulated on pushing through such a difficult trial with good control subjects. However, there is one concern that we have, which may alter the clinical conclusions that should be drawn. Patients for this trial were …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles